This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ube Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yuusuke Shiraishi: Innovator in Pharmaceutical Chemistry
Introduction
Yuusuke Shiraishi is a notable inventor based in Ube, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzotriazole derivatives. His research focuses on compounds that exhibit Keap1 inhibitory effects, which have potential applications in various therapeutic areas.
Latest Patents
Yuusuke Shiraishi holds a patent for a benzotriazole derivative. The present invention provides a compound that has Keap1 inhibitory effects and a pharmaceutical composition containing the same. Specifically, the invention includes a compound represented by a general formula, along with its pharmaceutically acceptable salts.
Career Highlights
Yuusuke Shiraishi is associated with Ube Corporation, where he has been able to apply his expertise in developing innovative pharmaceutical solutions. His work has contributed to the advancement of new therapeutic options in the pharmaceutical industry.
Collaborations
Yuusuke has collaborated with notable colleagues, including Yukinori Wada and Ken-ichi Komori. These collaborations have fostered a productive environment for innovation and research within Ube Corporation.
Conclusion
Yuusuke Shiraishi is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His contributions, particularly in the area of benzotriazole derivatives, highlight the importance of research and development in creating effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile